arrow
M

Michael J. Eck

Harvard Medical School
H指数:89
被引数:4.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

RAF isoform selectivity of MEK inhibitors and rational design of a covalent ARAF-MEK inhibitor

MEK抑制剂的RAF异构体选择性及共价ARAF-MEK抑制剂的理性设计

2026-10-230
OAAI
Deciphering the Structure−Activity Relationships Underpinning the Linkerology of Bivalent EGFR Inhibitors

解析支撑双价EGFR抑制剂连接体学的构效关系

2026-01-010
PRE
Author Correction: A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas

作者更正:FGFR 突变和共突变的多样化景观表明儿童低级别胶质瘤中存在潜在的治疗策略

2025-10-090
OA
A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas

FGFR变异和共突变多样性的景观表明儿科低级别胶质瘤存在潜在的治疗策略

2025-07-310
OAAI
Tilting the Scales toward EGFR Mutant Selectivity: Expanding the Scope of Bivalent Type V Kinase Inhibitors
2024-12-030
PRE
A ROLE FOR BRAF FUSION PARTNERS IN ONCOGENIC SIGNALING
2024-06-180
OAAI
ELUCIDATING THE ROLE OF FGFR1 ALTERATIONS IN PEDIATRIC GLIOMAS
2024-06-180
OAAI
BEYOND MAPK SIGNALING - GENOME-SCALE CRISPR/CAS9 SCREENS REVEAL NEW TARGETS FOR TREATMENT OF KIAA1549::BRAF-DRIVEN PEDIATRIC LOW-GRADE GLIOMA
2024-06-180
OAAI
Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors
2024-02-207
OAAI